| Literature DB >> 31801571 |
Jing Zhao1, Yuan Zhang1, Fengjiang Wei1, Jiani Song1, Zhi Cao2, Chen Chen3, Kai Zhang3, Shuzhi Feng4, Yaogang Wang5, Wei-Dong Li6.
Abstract
BACKGROUND: Although there is abundant evidence indicating the connection between triglyceride and type 2 diabetes mellitus (T2DM), few reports or cohort studies confirm that high TG concentration may predict the incidence of T2DM independently. Thus, we studied the association between triglyceride (TG) and T2DM in a male-dominated, middle and older aged cohort, Tianjin General Hospital Cohort. And we further verified our results in the China Health and Retirement Longitudinal Study (CHARLS).Entities:
Keywords: Dynamic cohort study; Survival analysis; Triglyceride; Type 2 diabetes mellitus
Year: 2019 PMID: 31801571 PMCID: PMC6894231 DOI: 10.1186/s12967-019-02156-3
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Baseline characteristics of subjects in Tianjin General Hospital Cohort
| Characteristics | Normal (< 1.7) | Borderline (1.7–2.25) | High (≥ 2.26) | |
|---|---|---|---|---|
| Male (%) | 3639 (73.9%) | 898 (77.3%) | 955 (82.5%) | < 0.001 |
| Age (years) | 62.05 ± 14.27 | 61.76 ± 13.12 | 58.83 ± 12.36 | < 0.001 |
| BMI (kg/m2) | 24.16 ± 3.14 | 25.36 ± 2.29 | 26.01 ± 2.78 | < 0.001 |
| Hypertension | 2015/4569 (40.9) | 550/1065 (47.3) | 539/1041 (46.5) | < 0.001 |
| FPG (mmol/L) | 5.08 ± 0.64 | 5.16 ± 0.66 | 5.17 ± 0.66 | < 0.001 |
| eGFR-mL/min/1.732 | 88.72 ± 19.60 | 86.57 ± 17.45 | 87.26 ± 23.18 | < 0.001 |
| TG (mmol/L)† | 1.09 ± 0.32 | 1.94 ± 0.16 | 3.39 ± 1.67 | < 0.001 |
| TC (mmol/L) | 4.76 ± 0.83 | 5.05 ± 0.86 | 5.21 ± 0.89 | < 0.001 |
| Urine dipstick result ≥ 1 + protein-no./total no (%) | 140/4290 (3.2) | 50/1058 (3.8) | 41/1014 (4.0) | 0.275 |
| Hyperuricemia | 541/4919 (11) | 234/1158 (20.1) | 347/1158 (30) | < 0.001 |
| SUA (μmol/L) | 319.74 ± 76.37 | 351.90 ± 75.85 | 375.08 ± 79.58 | < 0.001 |
| ALT (IU/L) | 21.75 ± 17.69 | 25.92 ± 15.25 | 28.59 ± 12.15 | < 0.001 |
Date are expressed as mean ± SD, n (%)
BMI body mass index, Hypertension, FPG fasting plasma glucose, TG plasma triglyceride level, TC total cholesterol, eGFR estimated glomerular filtration rate, hyperuricemia, SUA serum uric acid, ALT alanine aminotransferase
*P < 0.05 was considered statistically significant
†Grouped based on TG level: normal < 150 mg/dL; borderline high 150–199 mg/dL; high 200–499 mg/dL
Hazard ratios of TG levels for T2DM in the Tianjin General Hospital Cohort and in the CHARLS
| Tianjin General Hospital Cohort | CHARLS | |||
|---|---|---|---|---|
| Tianjin General Hospital Cohort | CHARLS | |||
| logTG | 2.58 (1.87–3.57) | 3.94 (2.64–5.87) | < 0.001 | 0.001 |
| Female | 0.69 (0.56–0.84) | 0.81 (0.65–1.00) | < 0.001 | 0.046 |
| Age (years) | 1.026 (1.02–1.03) | 1.02 (1.00–1.03) | < 0.001 | 0.005 |
| BMI (kg/m2) | 1.11 (1.09–1.14) | 1.10 (1.07–1.13) | < 0.001 | < 0.001 |
| Hypertension | 1.88 (1.59–2.22) | 1.37 (1.11–1.69) | < 0.001 | 0.004 |
| Hyperuricemia | 1.34 (1.10–1.63) | 0.64 (0.42–0.96) | < 0.001 | 0.033 |
TG plasma triglyceride level, BMI body mass index
*P < 0.05 was considered statistically significant
†Each time the value of hazard ratios changes by one unit, the risk doubles
Prospective analysis of associations between baseline triglyceride levels and incident T2DM in the Tianjin General Hospital Cohort and in the CHARLS
| Tianjin General Hospital Cohort | CHARLS | |||
|---|---|---|---|---|
| Tianjin General Hospital Cohort | CHARLS | |||
| Borderline† | ||||
| Model 1a | 1.42 (1.16–1.74) | 1.86 (1.44–2.40) | < 0.001 | < 0.001 |
| Model 2b | 1.45 (1.18–1.78) | 1.81 (1.40–2.33) | < 0.001 | < 0.001 |
| Model 3c | 1.30 (1.04–1.62) | 1.55 (1.20–2.00) | < 0.001 | 0.001 |
| High† | ||||
| Model 1a | 1.65 (1.36–2.00) | 2.76 (2.20–3.48) | < 0.001 | < 0.001 |
| Model 2b | 1.75 (1.44–2.12) | 2.74 (2.18–3.45) | < 0.001 | < 0.001 |
| Model 3c | 1.54 (1.24–1.90) | 2.20 (1.73–2.80) | < 0.001 | 0.001 |
*P < 0.05 was considered statistically significant
†Groups were classified based on TG concentration: 1, < 150 mg/dL; 2, 150–199 mg/dL; 3, 200–499 mg/dL
aModel 1: unadjusted baseline values of variables
bModel 2: model 1 adjusted for gender and age
cModel 3: was further adjusted for BMI, Hypertension, hyperuricemia
Fig. 1Kaplan–Meier survival analysis K–M curves for T2DM among three TG levels. †Groups of TG were defined as follows: 1, < 150 mg/dL (normal); 2, 150 mg/dL-199 mg/dL (borderline high); 3, 200–499 mg/dL (high); *P-value < 0.01 for log-rank test
Fig. 2Adjusted hazard ratios (95% confidence intervals) for incidence of T2DM stratified by sex, age, hypertension, body mass index, estimated glomerular filtration rate (eGFR), and history of hypertension